Strategic medical affairs expert with extensive experience in academic, government, pharmaceutical, biotechnology, healthcare payer, and agency settings. Combining global market knowledge and innovation to increase return on investment through interactions with all healthcare stakeholders including healthcare providers, payers and patients. Demonstrated leader with excellent written, verbal, organizational, and interpersonal skills. Expertise in multiple therapeutic areas, specializing in complex disease states (oncology, hematology and infectious disease). Author of 47 peer-reviewed publications.Specialties: Basic science research, clinical research (including phase 3 clinical trials), tissue banking, continuing medical education (CME), medical affairs, educational outcomes, publication planning, thought leader engagement, strategic medical communications, and health economic outcomes.